Somers, Klaartje
Wen, Victoria W.
Middlemiss, Shiloh M. C.
Osborne, Brenna http://orcid.org/0000-0002-0197-3010
Forgham, Helen
Jung, MoonSun
Karsa, Mawar
Clifton, Molly
Bongers, Angelika
Gao, Jixuan
Mayoh, Chelsea
Raoufi-Rad, Newsha
Kusnadi, Eric P.
Hannan, Kate M.
Scott, David A.
Kwek, Alan
Liu, Bing
Flemming, Claudia
Chudakova, Daria A.
Pandher, Ruby
Failes, Tim W.
Lim, James
Angeli, Andrea
Osterman, Andrei L.
Imamura, Toshihiko
Kees, Ursula R.
Supuran, Claudiu T.
Pearson, Richard B. http://orcid.org/0000-0001-5919-5090
Hannan, Ross D. http://orcid.org/0000-0002-2166-4493
Davis, Thomas P. http://orcid.org/0000-0003-2581-4986
McCarroll, Joshua
Kavallaris, Maria http://orcid.org/0000-0003-2309-898X
Turner, Nigel
Gudkov, Andrei V.
Haber, Michelle
Norris, Murray D.
Henderson, Michelle J.
Funding for this research was provided by:
This research was supported by NHMRC, Leukaemia Foundation, Anthony Rothe Memorial Trust, NSW Cancer Council, Cancer Institute NSW, Tenix Foundation and ISG Foundation.
Article History
Received: 11 December 2017
Revised: 21 August 2018
Accepted: 11 December 2018
First Online: 22 January 2019
Compliance with ethical standards
:
: Gudkov A.V. is a consultant of Oncotartis, Inc. which has licensed the CCI-006 compound from Children’s Cancer Institute.